Squarepoint
LUNG icon

Squarepoint’s Pulmonx LUNG Stock Holding History

Squarepoint’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
183,558
+101,066
+123% +$139K ﹤0.01% 3957
2026
Q1 		$106K Buy
82,492
+41,241
+100% +$68.1K ﹤0.01% 4057
2025
Q4 		$91.2K Buy
+41,251
New +$77.6K ﹤0.01% 4050
2025
Q3 		– Sell
-12,742
Closed -$33K – 4720
2025
Q2 		$33K Buy
12,742
+1,062
+9% +$4.19K ﹤0.01% 4355
2025
Q1 		$78.6K Sell
11,680
-79,775
-87% -$565K ﹤0.01% 4273
2024
Q4 		$621K Sell
91,455
-29,682
-25% -$195K ﹤0.01% 3535
2024
Q3 		$1M Sell
121,137
-23,272
-16% -$168K ﹤0.01% 2602
2024
Q2 		$916K Buy
144,409
+104,432
+261% +$803K ﹤0.01% 2617
2024
Q1 		$371K Buy
+39,977
New +$469K ﹤0.01% 3250
2023
Q1 		– Sell
-82,059
Closed -$692K – 3537
2022
Q4 		$692K Buy
82,059
+43,118
+111% +$410K ﹤0.01% 2080
2022
Q3 		$649K Sell
38,941
-80,745
-67% -$1.49M ﹤0.01% 2066
2022
Q2 		$1.76M Buy
+119,686
New +$2.47M 0.01% 1277
2022
Q1 		– Sell
-12,561
Closed -$403K – 3236
2021
Q4 		$403K Sell
12,561
-8,359
-40% -$305K ﹤0.01% 2289
2021
Q3 		$753K Buy
20,920
+14,778
+241% +$581K ﹤0.01% 1731
2021
Q2 		$271K Buy
+6,142
New +$267K ﹤0.01% 2604

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Squarepoint's LUNG Position: Q2 2026 in Review

Squarepoint increased its Pulmonx (LUNG) stake by 123% in Q2 2026, buying an estimated $139K and bringing the position to 183,558 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #3957.

Squarepoint first reported a position in LUNG in Q2 2021 and has held it in 15 quarters since. The position peaked at $1.76M in Q2 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Squarepoint held 183,558 shares of Pulmonx worth $239K as of Q2 2026.
  • Squarepoint bought 101,066 Pulmonx shares in Q2 2026, an estimated $139K.
  • Pulmonx made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3957 holding.
  • Squarepoint first reported a position in Pulmonx in Q2 2021 and has held it in 15 quarters since.
  • Squarepoint's Pulmonx position peaked at $1.76M in Q2 2022.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.